Search

Search bills, members, committees and pages...

Sign In

TIMOTHY CASEY

PreviousNext

16 federal lobbying filings, 2023 to 2026.

TIMOTHY CASEY is a registered lobbyist named on 16 federal lobbying filings, 2023 to 2026.

An LDA filing reports one registrant’s income from one client for everything they worked that quarter, so a total here is the sum of whole filings and never a price for one issue or one bill.

Firms

2 they have filed under, by filings.

RegistrantFilingsReported
FRESENIUS KABI USA LLC10—
THE UNITED STATES PHARMACOPEIAL CONVENTION6—

By year

Filings and what they reported, newest year first.

YearFilingsIncomeExpenses
20263—$360K
20254—$1M
20245—$1.3M
20234—$962.9K

Issues

The LDA issue codes the filings were filed under.

CodeIssueFilings
MMMMedicare/Medicaid10
PHAPharmacy10
TAXTaxation/Internal Revenue Code10
TRDTrade (domestic/foreign)10
HCRHealth Issues8
BUDBudget/Appropriations5
DEFDefense3
MANManufacturing2
TARTariff (miscellaneous tariff bills)1

Bills

The bills the filings name, by how many name them.

BillTitleFilings
H.R. 4191MAPS Act6
S. 1784MAPS Act6
H.R. 5304Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 20263
S. 2296National Defense Authorization Act for Fiscal Year 20263
S. 2587Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 20263
S. 3788CLEAR LABELS Act3
H.R. 4779National Security, Department of State, and Related Programs Appropriations Act, 20262
H.R. 8800National Defense Authorization Act for Fiscal Year 20271

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, newest first.

ClientRegistrantPeriodReportedPosted
THE UNITED STATES PHARMACOPEIAL CONVENTIONTHE UNITED STATES PHARMACOPEIAL CONVENTION2026 first_quarter$130KJul 20, 2026
THE UNITED STATES PHARMACOPEIAL CONVENTIONTHE UNITED STATES PHARMACOPEIAL CONVENTION2026 second_quarter$120KJul 20, 2026
THE UNITED STATES PHARMACOPEIAL CONVENTIONTHE UNITED STATES PHARMACOPEIAL CONVENTION2026 first_quarter$110KApr 21, 2026
THE UNITED STATES PHARMACOPEIAL CONVENTIONTHE UNITED STATES PHARMACOPEIAL CONVENTION2025 fourth_quarter$100KJan 20, 2026
THE UNITED STATES PHARMACOPEIAL CONVENTIONTHE UNITED STATES PHARMACOPEIAL CONVENTION2025 third_quarter$80KOct 20, 2025
THE UNITED STATES PHARMACOPEIAL CONVENTIONTHE UNITED STATES PHARMACOPEIAL CONVENTION2025 second_quarter$110KJul 21, 2025
FRESENIUS KABI USA LLCFRESENIUS KABI USA LLC2025 first_quarter$712.9KMay 6, 2025
FRESENIUS KABI USA LLCFRESENIUS KABI USA LLC2024 fourth_quarter$75KFeb 12, 2025
FRESENIUS KABI USA LLCFRESENIUS KABI USA LLC2024 third_quarter$75KNov 5, 2024
FRESENIUS KABI USA LLCFRESENIUS KABI USA LLC2024 second_quarter$75KAug 26, 2024
FRESENIUS KABI USA LLCFRESENIUS KABI USA LLC2024 second_quarter$554.5KAug 13, 2024
FRESENIUS KABI USA LLCFRESENIUS KABI USA LLC2024 first_quarter$554.5KApr 30, 2024
FRESENIUS KABI USA LLCFRESENIUS KABI USA LLC2023 fourth_quarter$75KFeb 5, 2024
FRESENIUS KABI USA LLCFRESENIUS KABI USA LLC2023 third_quarter$75KNov 29, 2023
FRESENIUS KABI USA LLCFRESENIUS KABI USA LLC2023 second_quarter$75KAug 4, 2023
FRESENIUS KABI USA LLCFRESENIUS KABI USA LLC2023 first_quarter$737.9KMay 3, 2023